| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3742a3de723e76b59815995017afe8ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_204d8bc1ebf5f452c37d9d309eb6a05b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd8a2c8dcf072681928109c1a0e6bc52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65427a772cb35b63365ed9eed590e6f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4725e8875fc6fda9f32f598ca0c887fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b1998250aa18e68fded47962afdfb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43c8a5f065ab8709de480e1b5c80b189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfc3d01102956ff6033aa81c7f159f3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_045f03152d92b2124b36c8a00746f4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f91db507a0e997d2d6a2d846dd5d74f8 |
| publicationDate |
2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2014228385-A1 |
| titleOfInvention |
6-[4-(1-H-imidazol-2-yl]piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity |
| abstract |
The invention provides heterocyclic amines according to Formula (I) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer. Formula (I). |
| priorityDate |
2013-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |